MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,717 Approvals
Showing 81 to 100 of 1,717 approvalsPage 5 of 86

Pomalidomide Krka

Authorisation: Jul 24, 2024

Durveqtix

Authorisation: Jul 24, 2024

Pomalidomide Zentiva

Authorisation: Jul 24, 2024

Ixchiq

Authorisation: Jun 28, 2024

Obgemsa

Authorisation: Jun 27, 2024

Obgemsa

Authorisation: Jun 27, 2024

Eribulin Baxter

Authorisation: Jun 27, 2024

Wezenla

Authorisation: Jun 20, 2024

Tofidence

Authorisation: Jun 20, 2024

Truqap

Authorisation: Jun 17, 2024

Fluenz

Authorisation: Jun 3, 2024

Fluenz

Authorisation: Jun 3, 2024

Agilus

Authorisation: May 29, 2024

Qalsody

Authorisation: May 29, 2024

Neoatricon

Authorisation: May 27, 2024

Neoatricon

Authorisation: May 27, 2024

Lytenava

Authorisation: May 27, 2024

Wyost

Authorisation: May 17, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.